Welcome
Support Centre
23 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)
ISRCTN ISRCTN87639321
ClinicalTrials.gov identifier
Public title The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)
Scientific title
Acronym BIAS
Serial number at source 14585
Study hypothesis The bisphosphonates will not alter clinical outcome in ankylosing spondylitis
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Ankylosing Spondylitis (AS)
Participants - inclusion criteria Age > 21, stable dose of non-steroidal anti-inflammatory drug (NSAID) for last four weeks. Need to fulfil New York Criteria for AS.
Participants - exclusion criteria 1. Systemic steroids for the last three months
2. Bisphosphonates in the last 12 months
3. Oesophageal disease or active peptic ulcer
4. Unable to give informed consent
5. Known Paget's Disease
6. Renal disease with creatinine >150 mmol/l, hypercalcaemia, osteomalacia, inflammatory bowel disease, known malignancy and reduced life expectancy <2 years
Anticipated start date 01/08/2004
Anticipated end date 31/08/2006
Status of trial Completed
Patient information material
Target number of participants 180
Interventions Placebo or Alendronate 70 mg weekly
Primary outcome measure(s) BAS-G
Secondary outcome measure(s) BASDAI, BASFI and BASRI, ESR, CRP, use of NSAIDs, bone density and vertebral deformity.
Sources of funding Arthritis Research Campaign 14585
Trial website http://www.arc.org.uk/research/grantdet.asp?Code=B0735
Publications
Contact name Dr  Ashok  Bhalla
  Address Dept of Rheumatology
Royal National Hospital for Rheumatic Diseases
Upper Borough Walls
  City/town Bath
  Zip/Postcode BA1 1RL
  Country United Kingdom
  Tel +44 (0)1225 473443
  Fax +44 (0)1225 473437
  Email ashok.bhalla@rnhrd-tr.swest.nhs.uk
Sponsor Royal National Hospital for Rheumatic Diseases (UK)
  Address Upper Borough Walls
  City/town Bath
  Zip/Postcode BA1 1RL
  Country United Kingdom
  Tel +44 (0)1225 473440
  Fax +44 (0)1225 473436
  Email Nicola.Carmichael@rnhrd-tr.swest.nhs.uk
Date applied 04/05/2005
Last edited 14/12/2010
Date ISRCTN assigned 23/05/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central